BGI Genomics Co Ltd (300676) - Total Liabilities

Latest as of March 2026: CN¥2.81 Billion CNY ≈ $410.62 Million USD

Based on the latest financial reports, BGI Genomics Co Ltd (300676) has total liabilities worth CN¥2.81 Billion CNY (≈ $410.62 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

BGI Genomics Co Ltd - Total Liabilities Trend (2012–2025)

This chart illustrates how BGI Genomics Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See how liquid is BGI Genomics Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

BGI Genomics Co Ltd Competitors by Total Liabilities

The table below lists competitors of BGI Genomics Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Remy Cointreau PA:RCO	France	€1.54 Billion
Tokai Carbon Korea Co. Ltd KQ:064760	Korea	₩40.75 Billion
Grupo Aval NYSE:AVAL	USA	$303.99 Trillion
ACME Solar Holdings Limited NSE:ACMESOLAR	India	Rs156.42 Billion
Netcompany Group A/S CO:NETC	Denmark	Dkr6.42 Billion
Pertamina Geothermal Energy JK:PGEO	Indonesia	Rp965.11 Million
Royce Value Closed Fund NYSE:RVT	USA	$4.50 Million
Nextnav Acquisition Corp NASDAQ:NN	USA	$285.19 Million

Liability Composition Analysis (2012–2025)

This chart breaks down BGI Genomics Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of BGI Genomics Co Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.60	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.33	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.25	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BGI Genomics Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BGI Genomics Co Ltd (2012–2025)

The table below shows the annual total liabilities of BGI Genomics Co Ltd from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥3.14 Billion ≈ $459.70 Million	-3.95%
2024-12-31	CN¥3.27 Billion ≈ $478.60 Million	-9.37%
2023-12-31	CN¥3.61 Billion ≈ $528.11 Million	-13.32%
2022-12-31	CN¥4.16 Billion ≈ $609.28 Million	-13.49%
2021-12-31	CN¥4.81 Billion ≈ $704.26 Million	-9.60%
2020-12-31	CN¥5.32 Billion ≈ $779.04 Million	+251.02%
2019-12-31	CN¥1.52 Billion ≈ $221.94 Million	+51.36%
2018-12-31	CN¥1.00 Billion ≈ $146.62 Million	+17.35%
2017-12-31	CN¥853.88 Million ≈ $124.95 Million	+9.82%
2016-12-31	CN¥777.52 Million ≈ $113.78 Million	+4.88%
2015-12-31	CN¥741.37 Million ≈ $108.49 Million	+27.08%
2014-12-31	CN¥583.40 Million ≈ $85.37 Million	-35.14%
2013-12-31	CN¥899.46 Million ≈ $131.62 Million	+5.41%
2012-12-31	CN¥853.31 Million ≈ $124.87 Million	--

About BGI Genomics Co Ltd

SHE:300676 China Diagnostics & Research

Market Cap

$2.17 Billion

CN¥14.86 Billion CNY

Market Cap Rank

#6037 Global

#1254 in China

Share Price

CN¥35.52

Change (1 day)

+3.92%

52-Week Range

CN¥32.88 - CN¥59.25

All Time High

CN¥248.01